| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918256 | Radiotherapy and Oncology | 2014 | 6 Pages |
Abstract
These long-term outcomes confirm that EBRT plus a single-fraction HDRB boost provides good results in treatment-related toxicity and biochemical control. In addition to the excellent clinical results, this fractionation schedule reduces physician workload, treatment-related expenses, patient discomfort and risks associated with anaesthesia. We believe these findings support the use of single-fractionation boost techniques.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ana Boladeras, Luigina Santorsa, Cristina Gutierrez, Evelyn Martinez, Joan Pera, Francisco Pino, José Francisco Suarez, Ferran Ferrer, Aurora DÃaz, Alfredo Polo, Ferran Guedea,